Thursday, June 29, 2006

Amarin Warm and Fuzzy

Amarin Corporation plc (Nasdaq:AMRN) keeps the corporate drum beating by announcing successful enrollment of enough candidates in the phase III clinical trials. The press release goes on to explain the potential merits/windfall that successful results may bring. No comment on when the trial may come to a close. No caveat’s that this is still a long way off. Just keeping everyone warm and fuzzy. Step right up and place your bets.